Notice Regarding SHIONOGI R&D Day 2026
Filed with TSE · · 1 page · English
Earlier from Shionogi &
- Shionogi Completes Acquisition of IntraBio Inc. and Adds AQNEURSA (levacetylleucine) to Growing Rare Disease Global Portfolio
- (Corrections / Correction of Numerical Data) Corrections to the Consolidated Financial Results for the Second Quarter of Fiscal Year 2026 (IFRS)
- (Corrections / Correction of Numerical Data) Corrections to the Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS)
- Notice Regarding Bridge Loan Financing in Connection with the Acquisition of IntraBio Inc.
- Notice of Partial Correction to “Notice of Revisions to Earnings Forecasts and Dividend Forecasts (Dividend Increase)”
Follow Shionogi & into a list and get an email when it puts out news.
Follow Shionogi &